Company Filing History:
4 out of 5 
1 out of 15 
1 out of 2,405 
Years Active: 2008-2024
Title: Richard Klinghoffer: Innovator in Cancer Treatment
Introduction
Richard Klinghoffer is a notable inventor based in Seattle, WA, who has made significant contributions to the field of cancer treatment. With a total of six patents to his name, Klinghoffer's work focuses on developing innovative pharmaceutical combinations aimed at combating various types of cancer, including leukemia, lymphoma, and triple-negative breast cancer.
Latest Patents
Klinghoffer's latest patents involve combination therapies that utilize CDK inhibitors alongside BCL-2 inhibitors or proteasome inhibitors. These therapies are designed to enhance the effectiveness of cancer treatment by targeting multiple pathways involved in cancer progression. His disclosures provide valuable insights into the formulation of these combination therapies, which hold promise for improving patient outcomes in the fight against cancer.
Career Highlights
Throughout his career, Richard Klinghoffer has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Presage Biosciences, Inc. and Ceptyr, Inc., where he has contributed to the advancement of cancer therapies through his innovative research and development efforts.
Collaborations
Klinghoffer has collaborated with esteemed colleagues in the field, including Joyoti Dey and Stephen Patrick Lewis. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in cancer treatment.
Conclusion
In summary, Richard Klinghoffer is a dedicated inventor whose work in developing pharmaceutical combinations for cancer treatment is making a significant difference in the medical field. His innovative approaches and collaborations continue to pave the way for advancements in cancer therapies.